Bisphosphonate treatment of bone disease
- 1Department of Endocrinology, Birmingham Children’s Hospital, UK
- 2Academic Unit of Child Health, Sheffield Children’s Hospital, University of Sheffield, UK
- Correspondence to:
Dr N J Shaw
Dept of Endocrinology, Birmingham Children’s Hospital, Steelhouse Lane, Birmingham B4 6NH, UK;
- Accepted 15 November 2004
In 1997 a review article on bisphosphonates in this journal identified 24 published articles relating to children at that time.1 Since then there has been a considerable increase in their use in clinical paediatric practice and research with there being nearly a further one hundred articles published at the time of writing.
Competing interests: NJS and NJB have received funding from Novartis and the Arthritism & Rheumatism Council for studies of bisphosphonates in osteogenesis imperfecta. NJB has acted as an independent consultant for Proctor & Gamble.